A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Inclusion criteria

• ✓. postmenopausal for at least 12 months prior to study drug administration;
• ✓. without a uterus and/or both ovaries; or
• ✓. Has been surgically sterile for at least 6 months prior to study drug administration.
• ✓. Hormonal methods or intrauterine device in use \> 90 days prior to study drug administration;
• ✓. Barrier methods plus spermicide in use at least 14 days prior to study drug administration; or
• ✓. Vasectomized partner (vasectomy must be performed 3 months prior to first study drug administration or in the alternative a zero sperm count will suffice).